Skip to main content
Equibles
BCDA logo

BCDA · BioCardia, Inc.

Track BCDA — free

Use BCDA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about BCDA

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.97 +0.04 (+4.82%) At close · Aug 14
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about our ability to continue as a going concern beyond one year from the date these financial statements are issued. While management believes this plan to raise additional funds will alleviate the conditions that raise substantial doubt, these plans are not entirely within their control and cannot be assessed as being probable of occurring.”
View the 10-Q filed Aug 12, 2026
Market Cap
$14.74M
Shares
15.14M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.97 Open$0.95 Day$0.91–0.98 52W close$0.77–2.27 Avg vol 30d341K Short int1.1M · 7.3% float · 5.1d Short vol56% Last earningsAug 12, 2026 DataMay 2024–Aug 2026 Filing10-Q · Aug 12

Raw chart and full-history price indicators begin at the captured split on May 30, 2024; bars on opposite sides are not compared.

Up next

Next earnings call
Nov 11, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 12, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Neutral Momentum Weak Sentiment Bullish Fundamentals Fair Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −16%
      below
      Price vs 50-day avg +4%
      above
      RSI (14) 56
      neutral
      MACD trend Positive
      52-week position 14%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Weak
      1-month return +17%
      trailing
      6-month return −14%
      trailing
      YTD return −22%
      this year
      Relative strength −28%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $1 › 200d $1 — 200d above 50d
      Institutional flow Accumulating
      +17% holders QoQ · +8 funds added
      Insider flow Accumulating
      Net +$133.6K over 90 days · 0% sells
      Short interest Falling
      7.31% of float · ▼ -17.6% MoM · 5.1 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      21 holders — mid 3-yr range
      Squeeze score 66
      elevated · 0–100
      Fundamentals
      Fair
      Revenue growth −17%
      Y/Y
      Gross margin 13%
      expanding
      Free cash flow $-7.4M
      Balance sheet $2.5M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 79%
      annualized · 1-yr
      Max drawdown −66%
      past year
      ATR 8.2%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Technicals

      trend & momentum for long-term holders Neutral
      2 · 3 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −16% Bearish
      Price vs 50-day avg
      +4% Bullish
      RSI (14)
      56 Neutral
      MACD trend
      Positive Bullish
      52-week position
      14% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $1 › 200d $1 — 200d above 50d
      Institutional flow Accumulating
      +17% holders QoQ · +8 funds added
      Insider flow Accumulating
      Net +$133.6K over 90 days · 0% sells
      Short interest Falling
      7.31% of float · ▼ -17.6% MoM · 5.1 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      21 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $1 Now $1 · 14% Range high $2
      vs 200-day avg -16% vs 50-day avg +4%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Versus peers

      Biotechnology — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      BCDA
      BioCardia, Inc.
      this stock
      		$14.74M -22.1% -16.8% — 7.3%
      ONC
      BeOne Medicines Ltd.
      		 $513.62B +14.4% +22179.2% 789.7 0.1%
      VRTX
      Vertex Pharmaceuticals Inc / Ma
      		 $128.19B +11.6% +46.2% 29.5 1.6%
      REGN
      Regeneron Pharmaceuticals, Inc.
      		 $82.72B +4.1% +20.8% 19.9 3.3%
      ARGX
      Argenx SE
      		 $52.94B +1.2% — — 2.1%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      21
      % held
      8.8%
      Net QoQ
      +646.8K sh
      Top holder
      CITIGROUP INC
      Held Float
      View
      Held by Funds
      Fund positions
      7
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      1.1M
      Days to cover
      5.1d
      Change
      -236.0K sh
      View
      Short Volume
      Short vol %
      56%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      307
      Value
      $279
      As of
      Jul 13, 2026
      View
      Off-Exchange
      Off-exchange %
      45.8%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$133.6K
      Buyers / Sellers
      2 / 0
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $479.0K
      Net income (FY)
      $-8.2M
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 12, 2026
      This year
      21
      View
      Proposed Sales
      Value
      $6.6K
      Shares
      3.3K
      Filed
      Dec 17, 2024
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 12, 2026
      View

      Performance

      Raw-price comparisons begin at the captured split on May 30, 2024; windows that need an earlier baseline remain unavailable.

      5D 20D 120D MTD YTD
      BCDA -0.6% +17.3% -13.8% +18.7% -22.1%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -1.0% +12.9% -27.6% +14.8% -36.0%
      Key facts CIK 925741 CUSIP 09060U606 13F (30d) 19 filings 19 filers Visit website

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)